Target intelligence / Profile preview

Rab geranylgeranyltransferase subunit beta

Molecular classification
Enzyme, Protein prenyltransferase, Heterodimeric transferase (beta subunit)
01

Overview

Rab geranylgeranyltransferase subunit beta (RABGGTB) forms part of the catalytic core of RabGGTase, a heterodimeric enzyme comprised of alpha and beta subunits. This enzyme is responsible for transferring geranylgeranyl groups to Rab GTPases, which is critical for their association with cellular membranes and, consequently, for regulating vesicular transport processes. The beta subunit contains most of the active site residues, forming an alpha-alpha barrel with a deep prenyl-binding pocket and coordinating catalytic metal ions (Zn²⁺ and Ca²⁺). RabGGTase does not recognize Rab substrates alone but requires Rab escort protein (REP) to present Rab GTPases for prenylation. Unlike type I enzyme, it works broadly on Rab proteins, outsourcing substrate recognition to REP, thereby enabling modification of many different Rab GTPases involved in trafficking, secretion, and possibly disease pathogenesis. Bisphosphonate drugs, used in the treatment of bone diseases, can inhibit RabGGTase, although their effectiveness varies in vivo. If you need details for the alpha subunit or the whole enzyme, those differ but are closely related. The beta subunit specifically refers to the structural and catalytic protein encoded by the *RABGGTB* gene.

Other names
protein geranylgeranyltransferase type II beta subunitRABGGTBGGTase-II beta subunit
02

Mechanism of action

Inhibition of RabGGTase prevents geranylgeranylation of Rab proteins, affecting their localization and function (resulting in disruption of vesicular trafficking and osteoclast activity)

03

Biological functions

Protein prenylation (specifically, addition of geranylgeranyl groups to Rab GTPases)Membrane traffickingRegulation of Rab protein membrane association
04

Disease associations

Bone resorption and osteoclast-related diseasesPotential involvement in cancer, based on the general role of Rab proteins in cell trafficking and signaling
05

Safety considerations

Systemic inhibition may disrupt vesicular trafficking in multiple cell types.May cause off-target effects due to widespread expression in many tissues (including nervous system, liver, and bone)
06

Interacting drugs

Nitrogen-containing bisphosphonates (e.g. risedronate, phosphonocarboxylate inhibitors have been shown to inhibit RabGGTase)

Beyond the preview

Go deeper on Rab geranylgeranyltransferase subunit beta.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rab geranylgeranyltransferase subunit beta.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call